Rchr
J-GLOBAL ID:200901087751216765   Update date: Sep. 13, 2023

OOTANI HAJIME

オオタニ ハジメ | OOTANI HAJIME
Affiliation and department:
Job title: Lecturer
Research field  (1): Cardiology
Papers (87):
  • Yoshioka K, Otani H, Shimazu T, Fujita M, Iwasaka T, Shiojima I. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats. American journal of physiology. Heart and circulatory physiology. 2015. 309. 10. H1782-H1791
  • Sato D, Otani H, Enoki C, Fujita M, Minato N, Iwasaka T. Phenotypic modulation and turnover of bone marrow-derived cells after myocardial infarction in rats. Cardiovascular pathology. 2011. 20. 3. 146-155
  • Okazaki T, Otani H, Shimazu T, Yoshioka K, Fujita M, Katano T, Ito S, Iwasaka T. Reversal of Inducible Nitric Oxide Synthase Uncoupling Unmasks Tolerance to Ischemia/Reperfusion Injury in the Diabetic Rat Heart. Journal of molecular and cellular cardiology. 2011. 50. 3. 534-544
  • Park H, Otani H, Oishi C, Fujikawa M, Yamashita K, Okazaki T, Sato D, Ueyama T, Iwasaka J, Yamamoto Y, et al. Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs. International journal of cardiology. 2011. 146. 3. 347-353
  • 朴幸男, 大谷肇, 大石千尋, 佐藤大祐, 上山敬直, 山本克浩, 岩坂潤二, 岩坂壽二. 著しい低酸素血症を来した右肺全域におよぶ肺動静脈瘻の1例. 日本心臓病学会誌. 2010. 5. 3. 228-231
more...
MISC (42):
  • Maulik N, McFadden D, Otani H, Thirunavukkarasu M, Parinandi NL. Antioxidants in longevity and medicine. Oxidative medicine and cellular longevity. 2013. 2013. Article No. 820679
  • Thirunavukkarasu M, Selvaraju V, Dunna NR, Foye JL, Joshi M, Otani H, Maulik N. Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat. International journal of cardiology. 2013. 168. 3. 2474-2480
  • Park H, Otani H, Noda T, Sato D, Okazaki T, Ueyama T, Iwasaka J, Yamamoto Y, Iwasaka T. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention. International journal of cardiology. 2013. 167. 4. 1547-1551
  • 久保田眞由美, 木村穣, 柳田優子, 齋藤瞳, 居原田善司, 岩坂潤二, 大谷肇, 岩坂壽二. 心臓リハビリテーションによる性格特性の変化の検討. 心臓リハビリテーション. 2013. 18. 2. 236-240
  • Otani H. Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease. Oxidative medicine and cellular longevity. 2013. 2013. Article No. 796891
more...
Books (4):
  • Therapeutic Strategies for Metabolic Syndrome and Lifestyle-related Disease,Nutritional and Therapeutic Interventions for Cardiovascular Diseases
    CRC press 2013
  • Strategy for avoiding cerebral complication during surgery for arch and distal arch aneurysm.,Cardio-aortic and Aortic Surgery.
    Springer-Verlag 2001
  • Strategy for avoiding cerebral complication during surgery for arch and distal arch aneurysm.「Cardio-aortic and Aortic Surgery.」
    Springer-Verlag 2001
  • 大動脈Open rupture手術例の検討「胸部・腹部大動脈瘤の治療-ステントグラフテイングを中心に2001年-」
    メデイカルトリビューン 2001 ISBN:4895892263
Lectures and oral presentations  (123):
  • Sepiapterin preventsu left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats
    (ESC Heartfailure2015 2015)
  • Heparin induces the mobilization of human multipotent circulating mesoangioblasts from the heart
    (ESC congress 2013 2013)
  • Heparin induces the mobilization of human multipotent circulating mesoangioblasts during cardiac catheterization.
    (第77回日本循環器学会学術集会 2013)
  • Multipotent human mesoangioblasts mobilization induced by heparin.
    (ESC Congress 2012 2012)
  • ヘパリンによる多能性ヒト Mesoangioblast の循環血中への動員
    (第11回日本再生医療学会総会 2012)
more...
Work history (1):
  • 2015/01/28 - 2019/03/31 Kansai Medical University Faculty of Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page